Table 1.
Isoform A | Function | Cancer type | Splicing type | Refs | |
---|---|---|---|---|---|
Isoform B | |||||
Proliferation | cyclin D1 | Tumour suppressor gene | Prostate tumours | Intron retention | [21] |
cyclin D1b | Associate with progression | ||||
Syk | Tumour suppressor | Breast tumours | Exon skipping | [26] | |
Syk(S) | Mammary tumour progression | ||||
RASSF5 | Tumourigenesis | Oesophageal cancer | Promoter usage | [25] | |
RASSF5A | Tumour suppressor | ||||
WT1 | Proliferation | Breast cancer | Exon skipping | [27, 100] | |
WT1iso | Development & progression | ||||
Metastasis | CD44 | Drive metastasis | Breast cancer | Addition of amino acids | [30] |
CD44V6 | Pro-metastatic molecule | ||||
CrkII | Migration | Glioblastoma | Exon skipping | [101] | |
CrkI | Promote cell migration | ||||
KLF6 | Tumour suppressor gene | Lung cancer | 5′- SS | [34] | |
KLF6-SV1 | Driver of tumour metastasis | ||||
VEGFA | Metastasis | Sarcoma | Exon 8 | [35] | |
VEGFA iso | Advantage for metastasis | ||||
Apoptosis | BCL-Xs | Pro-apoptosis | Many cancer types | 5′-SS | [75] |
BCL-XL | Anti-apoptosis | ||||
nCLu | Pro-apoptotic | Many cancer types | Frame shift | [41] | |
sCLu | Pro-survival | ||||
ELF2A | Pro-apoptosis | Cancer cell lines | 5′-SS | [42] | |
ELF2B | Anti-apoptosis | ||||
RIP3 | Pro-apoptosis | Colon & lung cancer | Intron retention | [43] | |
RIP3γ | Anti-apoptosis | ||||
Drug resistance | AR | Chemosensitivity | Prostate cancer | Exon skipping | [70] |
AR-v7 | Chemoresistance | ||||
BRCA1 | Repair of DNA break | Breast cancer | Exon skipping | [49] | |
BRCA1Δ11 | Chemoresistance | ||||
c-FLIP(L) | Anti-apoptosis | Pancreatic cancer | Truncated C-terminus | [50] | |
c-FLIP(S) | Drug resistance | ||||
Survivin | Anti-apoptosis | Neoplastc cells | Intron retention | [48] | |
Survivin 3B | Promote chemoresistance | ||||
Radiotherapy | sCLu | Genomic instability | Breast cancer cells | 5′-SS | [53] |
nCLu | Pro-death factor | ||||
Mcl-1L | Anti-apoptotic | OSCC | Exon skipping | [54] | |
Mcl-1S | Pro-apoptotic | ||||
NPM1 | Radioresistance | Cervical cancer | Intron retention | [55] | |
NPM2 | Radiosensitivity | ||||
Tap73 | Pro-apoptosis | Cervical cancer | Exon skipping | [60] | |
ΔNp73 | Anti-apoptosis |